Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venture Investors Early Stage Fund IV Limited Partnership is a Midwest-focused early-stage venture capital fund specializing in life sciences, engineering, and information technology, with a strong emphasis on university spinouts. It invests in seed and early-stage companies, often supporting academic research commercialization, with a portfolio spanning biotech, healthcare, advanced manufacturing, and IT. The fund has made notable investments in companies such as Akebia Therapeutics, Cellectar Biosciences, and Aerpio Pharmaceuticals, but it is not a biotech or pharma company itself—it is an investment vehicle with a diversified sector focus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venture Investors Early Stage Fund IV.